Comparison of Oral Versus Vaginal Misoprostol for Induction of Labour at Term

Background: To compare the efficacy and safety of oral versus vaginal administration of Misoprostol for induction of labour at term. Methods: In this interventional study primigravida were assigned in two groups; A and B, using non-probability convenient sampling technique. Group-A (n=50) had Misop...

Full description

Bibliographic Details
Main Author: Zoqeen Akhtar
Format: Article
Language:English
Published: Rawalpindi Medical University 2010-12-01
Series:Journal of Rawalpindi Medical College
Subjects:
Online Access:https://www.journalrmc.com/index.php/JRMC/article/view/667
id doaj-6c5cee15a60c4717901e5df71a14ca80
record_format Article
spelling doaj-6c5cee15a60c4717901e5df71a14ca802020-11-25T03:42:33ZengRawalpindi Medical UniversityJournal of Rawalpindi Medical College1683-35621683-35702010-12-01152Comparison of Oral Versus Vaginal Misoprostol for Induction of Labour at TermZoqeen Akhtar0Department of Gynaecology and Obstetrics,Central Park Medical College, Lahore Background: To compare the efficacy and safety of oral versus vaginal administration of Misoprostol for induction of labour at term. Methods: In this interventional study primigravida were assigned in two groups; A and B, using non-probability convenient sampling technique. Group-A (n=50) had Misoprostol orally, while group-B (n=50) received the drug by vaginal route. Dosage was 100 μg four hours apart in group-A and six hours apart in group-B. Maximum of four doses were given. Main outcome measures of study were labour-induction interval, labour-delivery interval, mode of delivery, neonatal outcome and feto-maternal complications. Results: The mean dosage requirement for induction of labour in groups A and B was 2.1±1.1 and 2.4±1.8 (p-0.23) respectively. Mean labour-induction interval in group A and B were 7.5±4.2 and 7.3±4.1 (p-0.87) hours respectively, which is not significant statistically. Mean labour delivery interval was shorter in vaginal group (4.9±2.7 hours) versus oral group(6.0±2.2) hours (p-0.04). Need for Oxytocin augmentation was less in vaginal group (21%) versus oral group (68%) (p-0.009). There was no statistical difference between the groups with respect to mode of delivery and neonatal outcome. The incidence of hyper-stimulation was similar in both groups. Conclusion:Misoprostol is a cost effective alternate for induction of labour. Misoprostol through vaginal route results in successful cervical ripening, less need for oxytocin and shorter time to delivery with acceptable safety profile. https://www.journalrmc.com/index.php/JRMC/article/view/667Induction labourMisoprostol,primigravidamaternal complicationfetal complication
collection DOAJ
language English
format Article
sources DOAJ
author Zoqeen Akhtar
spellingShingle Zoqeen Akhtar
Comparison of Oral Versus Vaginal Misoprostol for Induction of Labour at Term
Journal of Rawalpindi Medical College
Induction labour
Misoprostol,
primigravida
maternal complication
fetal complication
author_facet Zoqeen Akhtar
author_sort Zoqeen Akhtar
title Comparison of Oral Versus Vaginal Misoprostol for Induction of Labour at Term
title_short Comparison of Oral Versus Vaginal Misoprostol for Induction of Labour at Term
title_full Comparison of Oral Versus Vaginal Misoprostol for Induction of Labour at Term
title_fullStr Comparison of Oral Versus Vaginal Misoprostol for Induction of Labour at Term
title_full_unstemmed Comparison of Oral Versus Vaginal Misoprostol for Induction of Labour at Term
title_sort comparison of oral versus vaginal misoprostol for induction of labour at term
publisher Rawalpindi Medical University
series Journal of Rawalpindi Medical College
issn 1683-3562
1683-3570
publishDate 2010-12-01
description Background: To compare the efficacy and safety of oral versus vaginal administration of Misoprostol for induction of labour at term. Methods: In this interventional study primigravida were assigned in two groups; A and B, using non-probability convenient sampling technique. Group-A (n=50) had Misoprostol orally, while group-B (n=50) received the drug by vaginal route. Dosage was 100 μg four hours apart in group-A and six hours apart in group-B. Maximum of four doses were given. Main outcome measures of study were labour-induction interval, labour-delivery interval, mode of delivery, neonatal outcome and feto-maternal complications. Results: The mean dosage requirement for induction of labour in groups A and B was 2.1±1.1 and 2.4±1.8 (p-0.23) respectively. Mean labour-induction interval in group A and B were 7.5±4.2 and 7.3±4.1 (p-0.87) hours respectively, which is not significant statistically. Mean labour delivery interval was shorter in vaginal group (4.9±2.7 hours) versus oral group(6.0±2.2) hours (p-0.04). Need for Oxytocin augmentation was less in vaginal group (21%) versus oral group (68%) (p-0.009). There was no statistical difference between the groups with respect to mode of delivery and neonatal outcome. The incidence of hyper-stimulation was similar in both groups. Conclusion:Misoprostol is a cost effective alternate for induction of labour. Misoprostol through vaginal route results in successful cervical ripening, less need for oxytocin and shorter time to delivery with acceptable safety profile.
topic Induction labour
Misoprostol,
primigravida
maternal complication
fetal complication
url https://www.journalrmc.com/index.php/JRMC/article/view/667
work_keys_str_mv AT zoqeenakhtar comparisonoforalversusvaginalmisoprostolforinductionoflabouratterm
_version_ 1724524282988462080